Mazdutide
A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
Innovent · Phase 1 · Completed · Enrollment 48
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| warfarin+atorvastatin+IBI362 | Obesity or overweight | n/r | n/r | n/r | n/r |
| metformin+digoxin+IBI362 | Obesity or overweight | n/r | n/r | n/r | n/r |